Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Management of Canadian Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the Real-World

Anthea Peters, Grzegorz S. Nowakowski, Rosy Dabas, Theresa Amoloja, Zhenyi Xue, Caroline Koch, Eva E. Waltl, Isabelle Fleury

Blood (2022) 140 (Supplement 1): 3811–3813.

https://doi.org/10.1182/blood-2022-158550

Published: 2022

Journal Articles

High Pre-HCT Exposure to Thymoglobulin Is Associated with a Low Incidence of Relapse

Rosy Dabas, BSc, MSc, Kareem Jamani, MD, Bill Kangarloo, M.Sc, Poonam Dharmani-Khan, PhD, Don Morris, MD PhD FRCPC, Douglas Mahoney, PhD, Andrew Daly, MD, Faisal M Khan, PhD D (ABHI), Jan Storek, MD PhD

Blood (2018) 132 (Supplement 1): 4605.

https://doi.org/10.1182/blood-2018-99-117332

Published: 2018

Journal Articles

Intermediate Post-HCT Exposure to Thymoglobulin Minimizes Mortality and High Exposure Minimizes the Composite of Death, Relapse or Chronic Graft-Versus-Host Disease

Kareem Jamani, MD, Rosy Dabas, BSc, MSc, Poonam Dharmani-Khan, PhD, Andrew Daly, MD, Jan Storek, MD PhD

Blood (2017) 130 (Supplement 1): 3245.

https://doi.org/10.1182/blood.V130.Suppl_1.3245.3245

Published: 2017

Journal Articles

Rabbit Anti-Thymocyte Globulin Kills Leukemic Stem Cells to a Greater Degree Than Healthy Hematopoietic Stem Cells

Rosy Dabas, BSc, MSc, Poonam Dharmani-Khan, PhD, Monica Modi, MD, Tiffany Van Slyke, MD, Joanne Luider, BSc, ART, MLT, Joseph M. Brandwein, MD FRCPC, Don Morris, MD PhD FRCPC, Andrew Daly, MD, Faisal M Khan, PhD D (ABHI), Jan Storek, MD PhD

Blood (2017) 130 (Supplement 1): 5511.

https://doi.org/10.1182/blood.V130.Suppl_1.5511.5511

Published: 2017

Journal Articles

Anti-Thymocyte Globulin Kills Leukemic Stem Cells in Vitro

Rosy Dabas, M.Sc., B.Sc., Poonam Dharmani, PhD, Monica Modi, MD, Tiffany Van Slyke, Joanne Luider, Joseph M. Brandwein, MD FRCPC, Don Morris, Andrew Daly, MD FRCPC, Faisal M Khan, PhD D (ABHI), Jan Storek, MD PhD

Blood (2016) 128 (22): 4616.

https://doi.org/10.1182/blood.V128.22.4616.4616

Published: 2016

Journal Articles

Antithymocyte Globulin at Clinically Relevant Concentration Kills Leukemic Blasts

Rosy Dabas, Rachelle Lee, Maria Theresa Servito, Poonam Dharmani Khan, Monica Modi, MD, Tiffany Van Slyke, Joanne Luider, Caylib Durand, Loree Larratt, MD, Joseph Brandwein, MD FRCPC, Andrew Daly, MD FRCPC, Faisal M Khan, PhD D (ABHI), Jan Storek, MD PhD

Blood (2015) 126 (23): 5481.

https://doi.org/10.1182/blood.V126.23.5481.5481

Published: 2015

NARROW

Management of Canadian Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the Real-World

High Pre-HCT Exposure to Thymoglobulin Is Associated with a Low Incidence of Relapse

Intermediate Post-HCT Exposure to Thymoglobulin Minimizes Mortality and High Exposure Minimizes the Composite of Death, Relapse or Chronic Graft-Versus-Host Disease

Rabbit Anti-Thymocyte Globulin Kills Leukemic Stem Cells to a Greater Degree Than Healthy Hematopoietic Stem Cells

Anti-Thymocyte Globulin Kills Leukemic Stem Cells in Vitro

Antithymocyte Globulin at Clinically Relevant Concentration Kills Leukemic Blasts

Email alerts

ASH Publications

American Society of Hematology

Management of Canadian Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the Real-World

High Pre-HCT Exposure to Thymoglobulin Is Associated with a Low Incidence of Relapse

Intermediate Post-HCT Exposure to Thymoglobulin Minimizes Mortality and High Exposure Minimizes the Composite of Death, Relapse or Chronic Graft-Versus-Host Disease

Rabbit Anti-Thymocyte Globulin Kills Leukemic Stem Cells to a Greater Degree Than Healthy Hematopoietic Stem Cells

Anti-Thymocyte Globulin Kills Leukemic Stem Cells in Vitro

Antithymocyte Globulin at Clinically Relevant Concentration Kills Leukemic Blasts

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only